Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $65.50 $77.98 Friday, 10th May 2024 AXSM stock ended at $72.50. This is 1.60% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 4.90% from a day low at $72.40 to a day high of $75.95.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Dec 16, 2022 $76.35 $79.67 $75.61 $78.40 1 175 937
Dec 15, 2022 $79.42 $80.47 $76.54 $77.46 795 935
Dec 14, 2022 $79.45 $81.16 $77.04 $79.72 802 982
Dec 13, 2022 $80.00 $82.00 $78.42 $79.45 850 743
Dec 12, 2022 $75.00 $79.52 $73.65 $79.37 1 019 515
Dec 09, 2022 $77.91 $78.79 $74.61 $74.86 808 080
Dec 08, 2022 $77.83 $79.97 $75.80 $77.85 899 679
Dec 07, 2022 $75.50 $79.10 $74.02 $78.16 1 180 413
Dec 06, 2022 $76.37 $78.18 $73.58 $75.26 1 080 208
Dec 05, 2022 $76.60 $80.87 $75.18 $77.29 2 372 194
Dec 02, 2022 $71.48 $78.00 $70.52 $76.90 2 040 801
Dec 01, 2022 $72.13 $73.76 $70.43 $71.97 1 034 898
Nov 30, 2022 $71.17 $74.08 $69.26 $72.29 1 643 390
Nov 29, 2022 $75.50 $75.98 $70.40 $70.84 2 951 600
Nov 28, 2022 $71.04 $79.68 $68.12 $74.74 10 741 789
Nov 25, 2022 $56.02 $57.17 $55.31 $56.82 327 439
Nov 23, 2022 $57.76 $58.04 $55.97 $56.22 771 423
Nov 22, 2022 $57.05 $59.98 $56.88 $57.23 1 096 273
Nov 21, 2022 $56.00 $57.95 $55.26 $56.98 914 297
Nov 18, 2022 $52.24 $55.97 $49.60 $55.85 856 597
Nov 17, 2022 $50.29 $54.30 $49.81 $52.57 828 034
Nov 16, 2022 $54.80 $55.25 $51.63 $51.99 684 870
Nov 15, 2022 $55.70 $59.26 $54.10 $56.01 1 146 882
Nov 14, 2022 $59.10 $59.53 $54.60 $55.05 1 178 101
Nov 11, 2022 $59.73 $60.00 $54.40 $58.44 1 433 135
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT